Literature DB >> 14636874

Evaluation of the analytic performances of the new HPLC system HLC-723 G7 for the measurement of hemoglobin A1c.

Alessandro Terreni1, Renata Paleari, Anna Caldini, Agostino Ognibene, Andrea Mosca, Gianni Messeri.   

Abstract

OBJECTIVES: The analytical performance of a new automated HPLC system, for the determination of HbA1C in blood (Tosoh HLC-723 G7), was studied. DESIGN AND METHODS: The study design included the evaluation of imprecision, linearity, interference and carryover. Comparison study was performed by comparing HbA1C results with those obtained from an established method (Bio-Rad Variant II).
RESULTS: Total imprecision was less than 1.34% and the results were linear up to 17.2% HbA1C. The method showed a wide analytical range, and no carryover between specimens. Comparison study yielded, r=0.989, Sy.x=0.255, regression equation (y=0.9895x-0.35); Bland-Altman plot showed a mean bias=- 0.43% HbA1C with confidence limits ranging from -0.48% to -0.38% HbA1C. The presence of abnormal hemoglobin was clearly revealed, and no interference from labile HbA1C was apparent.
CONCLUSION: The HLC-723 G7 instrument seems to be a reliable system for routine assay of HbA1C.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636874     DOI: 10.1016/s0009-9120(03)00116-4

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  A1C to detect diabetes in healthy adults: when should we recheck?

Authors:  Osamu Takahashi; Andrew J Farmer; Takuro Shimbo; Tsuguya Fukui; Paul P Glasziou
Journal:  Diabetes Care       Date:  2010-06-21       Impact factor: 19.112

2.  A1C underestimates glycemia in HIV infection.

Authors:  Peter S Kim; Christian Woods; Patrick Georgoff; Dana Crum; Alice Rosenberg; Margo Smith; Colleen Hadigan
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.